The diversity of SNCA transcripts in neurons, and its impact on antisense oligonucleotide therapeutics
Evans, J. R.; Gustavsson, E. K.; Doykov, I.; Murphy, D.; Virdi, G.; Lachica, J.; Rontgen, A.; Murtada, M. H.; Pang, C. W.; Macpherson, H.; Wernick, A. I.; Toomey, C. E.; Athauda, D.; Choi, M.; Hardy, J.; Wood, N. W.; Vendruscolo, M.; Mills, K.; Heywood, W.; Ryten, M.; Gandhi, S.
Show abstract
The role of the SNCA gene locus in driving Parkinsons disease (PD) through rare and common genetic variation is well-recognized, but the transcriptional diversity of SNCA in vulnerable cell types remains unclear. We performed SNCA long-read RNA sequencing in human dopaminergic neurons and show that annotated SNCA transcripts account for only 5% of expression. Rather, the majority of expression (75%) at the SNCA locus originates from transcripts with alternative 5 and 3 untranslated regions. Importantly, 10% originates from transcripts encoding open reading frames not previously annotated, which are translated and detectable in human postmortem brain. Defining the 3 untranslated regions enabled the rational design of antisense oligonucleotides targeting the majority of SNCA transcripts, leading to the effective reversal of PD pathology, including protein aggregation, mitochondrial dysfunction, and toxicity. Resolving the complexity of the SNCA transcriptional landscape impacts RNA therapies and highlights differences in protein isoforms and their contribution to disease.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Protein aggregation and calcium dysregulation are the earliest hallmarks of synucleinopathy in human midbrain dopaminergic neurons 96%
- A brain-shuttled antibody targeting alpha synuclein aggregates for the treatment of synucleinopathies 96%
- MJF-14 proximity ligation assay detects early non-inclusion alpha-synuclein pathology with enhanced specificity and sensitivity 95%
Similar papers in this journal
- Modeling Alpha-Synuclein Pathology in a Human Brain-Chip to Assess Blood-Brain Barrier Disruption in Parkinson's Disease 96%
- Mitigating a TDP-43 proteinopathy by targeting ataxin-2 using RNA-targeting CRISPR effector proteins 95%
- Nuclear and cytoplasmic huntingtin inclusions exhibit distinct biochemical composition, interactome and ultrastructural properties 95%
Similar papers in this journal
- Single cell spatial transcriptomic and translatomic profiling of dopaminergic neurons in health, aging and disease 96%
- A Mitochondrial Inside-Out Iron-Calcium Signal Reveals Drug Targets for Parkinsons Disease 95%
- ALS molecular subtypes are a combination of cellular, genetic, and pathological features learned by deep multiomics classifiers 94%
Similar papers in this journal
- VMAT2 dysfunction impairs vesicular dopamine uptake, driving its oxidation and α-synuclein pathology in DJ-1-linked Parkinson's disease neurons 95%
- Identification of distinct pathological signatures induced by patient-derived α-synuclein structures in non-human primates 94%
- Phosphoglycerate kinase 1 is a central leverage point in Parkinson's disease driven neuronal metabolic deficits 94%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.